vTv Therapeutics (VTVT) Operating Leases (2019 - 2025)
vTv Therapeutics (VTVT) has disclosed Operating Leases for 7 consecutive years, with $125000.0 as the latest value for Q1 2025.
- Quarterly Operating Leases changed 0.0% to $125000.0 in Q1 2025 from the year-ago period, while the trailing twelve-month figure was $125000.0 through Mar 2025, changed 0.0% year-over-year, with the annual reading at $169000.0 for FY2024, 0.0% changed from the prior year.
- Operating Leases hit $125000.0 in Q1 2025 for vTv Therapeutics, down from $169000.0 in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $633000.0 in Q1 2021 to a low of $125000.0 in Q1 2024.
- Historically, Operating Leases has averaged $337176.5 across 5 years, with a median of $333000.0 in 2022.
- Biggest five-year swings in Operating Leases: grew 2.95% in 2023 and later plummeted 72.47% in 2024.
- Year by year, Operating Leases stood at $492000.0 in 2021, then plummeted by 31.3% to $338000.0 in 2022, then plummeted by 50.0% to $169000.0 in 2023, then changed by 0.0% to $169000.0 in 2024, then dropped by 26.04% to $125000.0 in 2025.
- Business Quant data shows Operating Leases for VTVT at $125000.0 in Q1 2025, $169000.0 in Q4 2024, and $213000.0 in Q3 2024.